By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ember Therapeutics 

29 Newbury Street

Boston  Massachusetts  02116  U.S.A.
Phone: n/a Fax: n/a


Company News
Ember Therapeutics Announces Engagement Of Maxim Group LLC To Provide Strategic Advisory Services 5/2/2017 11:03:39 AM
Ember Therapeutics Signs Endorsement Deal With 12 Time Olympic Medalist Ryan Lochte 10/4/2016 8:05:35 AM
Ember Therapeutics Acquires Dermasilk Brands 9/13/2016 10:03:47 AM
Knight Therapeutics And Ember Therapeutics Expand Distribution Partnership 7/6/2016 7:52:49 AM
Ember Therapeutics Announce Initial Positive Results From A Phase 2 Trial Of BMP-7 In Patients With Moderate Osteoarthritis Of The Knee 10/20/2015 7:47:53 AM
Ember Therapeutics and Third Rock Ventures — A Case Study in the Risks of Biotech Investments 9/10/2015 6:31:49 AM
Ember Therapeutics Raises Up To $6M And Establishes Commercial Partnership With Knight Therapeutics 8/7/2015 6:18:39 AM
Ember Therapeutics And Mariel Therapeutics Enter Definitive Merger Agreement Creating A Strong Diversified Company 3/12/2015 7:01:07 AM
Ember Therapeutics Broadens Brown Fat Small Molecule Drug Discovery Portfolio, Secures Exclusive License Options to Intellectual Property for Three Small Molecule Targets 10/4/2012 10:10:55 AM
Ember Therapeutics Announces Cell Publication of Key Data Showing TRPV4 Inhibition Activates Brown/Beige Fat and Protects Against Obesity, Inflammation and Insulin Resistance 9/27/2012 10:26:57 AM